Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKDC | P78527 | 2/20 | 0.34 |
| ▸ | CHRNB4 | P30926 | 2/20 | 0.33 |
| ▸ | CHRNA3 | P32297 | 2/20 | 0.33 |
| ▸ | CHRNA7 | P36544 | 2/20 | 0.33 |
| ▸ | PPARG | P37231 | 3/20 | 0.32 |
| ▸ | PPARA | Q07869 | 3/20 | 0.32 |
| ▸ | PIM1 | P11309 | 2/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | PPARD | Q03181 | 1/20 | 0.32 |
| ▸ | CA12 | O43570 | 2/20 | 0.31 |
| ▸ | CA1 | P00915 | 2/20 | 0.31 |
| ▸ | CA2 | P00918 | 2/20 | 0.31 |
| ▸ | CA9 | Q16790 | 2/20 | 0.31 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.31 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.31 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.31 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.31 |
| ▸ | LPL | P06858 | 1/20 | 0.31 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23056755 | 0.94 | PRKDC (0.37) | PRKDCCHRNB4CHRNA3CHRNA7CYP1A1 | |
| SCHEMBL25027461 | 0.93 | PRKDC (0.36) | PRKDCCHRNB4CHRNA3CHRNA7PPARG | |
| SCHEMBL23056754 | 0.92 | CHRNB4 (0.38) | PRKDCCHRNB4CHRNA3CHRNA7PPARG | |
| SCHEMBL23056758 | 0.92 | CHRNB4 (0.38) | PRKDCCHRNB4CHRNA3CHRNA7PPARG | |
| SCHEMBL25027460 | 0.92 | CHRNB4 (0.37) | PRKDCCHRNB4CHRNA3CHRNA7PPARG | |
| SCHEMBL23056818 | 0.91 | CHRNB4 (0.36) | PRKDCCHRNB4CHRNA3CHRNA7PPARG | |
| SCHEMBL22756962 | 0.91 | PRKDC (0.38) | PRKDCCHRNB4CHRNA3CHRNA7PPARG | |
| SCHEMBL23056819 | 0.91 | PRKDC (0.38) | PRKDCCHRNB4CHRNA3CHRNA7PPARG | |
| SCHEMBL23056759 | 0.87 | PRKDC (0.35) | PRKDCCHRNB4CHRNA3CHRNA7PPARG | |
| SCHEMBL23056760 | 0.87 | CHRNB4 (0.36) | PRKDCCHRNB4CHRNA3CHRNA7PPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11730054-B2 | Compound having dibenzofuran and naphthalene structures, and organic electroluminescent element using same | IDEMITSU KOSAN CO., LTD. (JP) | 2023-08-15 | — | — | US | disclosed |
| US-11730054-B2 | Compound having dibenzofuran and naphthalene structures, and organic electroluminescent element using same | IDEMITSU KOSAN CO., LTD. (JP) | 2023-08-15 | — | — | US | disclosed |
| US-20230047512-A1 | COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME | IDEMITSU KOSAN CO.,LTD. (JP) | 2023-02-16 | — | — | US | disclosed |
| US-20210066611-A1 | COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME | IDEMITSU KOSAN CO,. LTD. (JP) | 2021-03-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210066611-A1 | COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME | LEF1, RPL19, ELP1 | PRKDC 4875/4885CHRNB4 2083/4885CHRNA3 3163/4885 |
| US-11730054-B2 | Compound having dibenzofuran and naphthalene structures, and organic electroluminescent element using same | LEF1, TCF4, RPL19 | PRKDC 4844/4885CHRNB4 1793/4885CHRNA3 3195/4885 |
| US-20230047512-A1 | COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME | LEF1, RPL19, ELP1 | PRKDC 4875/4885CHRNB4 2083/4885CHRNA3 3163/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.